Diabetes, obesity & metabolism

Drug Treatments for Overweight or Obesity in Children and Teens: A Review and Comparison of Clinical Trials

Updated

Abstract

A total of 41 randomized controlled trials involving 3923 participants were analyzed.

  • Semaglutide resulted in a 20.40% decrease in the 95th BMI percentile compared to lifestyle modification alone.
  • An additional 500 patients per 1000 person-years achieved a ≥ 5% BMI reduction with semaglutide.
  • Phentermine-topiramate produced an 18.35% reduction in the 95th BMI percentile, with 554 additional responders per 1000 person-years.
  • Liraglutide and exenatide also significantly reduced the 95th BMI percentile, but to a lesser extent than semaglutide and phentermine-topiramate.
  • Phentermine-topiramate may be the optimal adjunct for weight management due to its favourable tolerability.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free